Article thumbnail
Location of Repository

Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration

By Suzana Gispert, Filomena Ricciardi, Alexander Kurz, Mekhman Azizov, Hans-Hermann Hoepken, Dorothea Becker, Wolfgang Voos, Kristina Leuner, Walter E. Müller, Alexei P. Kudin, Wolfram S. Kunz, Annabelle Zimmermann, Jochen Roeper, Dirk Wenzel, Marina Jendrach, Moisés García-Arencíbia, Javier Fernández-Ruiz, Leslie Huber, Hermann Rohrer, Miguel Barrera, Andreas S. Reichert, Udo Rüb, Amy Chen, Robert L. Nussbaum and Georg Auburger
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2686165
Provided by: PubMed Central

Suggested articles

Citations

  1. (2008). alpha-Synucleinopathy models and human neuropathology: similarities and differences.
  2. (2003). alphaSynuclein locus triplication causes Parkinson’s disease.
  3. (2006). Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila.
  4. (1997). Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment.
  5. (2003). BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential.
  6. (2005). Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease.
  7. (2004). Doubleknockout mice for alpha- and beta-synucleins: effect on synaptic functions.
  8. (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
  9. (2009). Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin. Experimental neurology 215:
  10. (2004). Hereditary early-onset Parkinson’s disease caused by mutations in PINK1.
  11. (2006). High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.
  12. (2007). Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
  13. (1999). Import of carrier proteins into mitochondria.
  14. (2002). Insertion and assembly of human tom7 into the preprotein translocase complex of the outer mitochondrial membrane.
  15. (2005). K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.
  16. (2004). Knockdown of MTP18, a novel phosphatidylinositol 3-kinase-dependent protein, affects mitochondrial morphology and induces apoptosis.
  17. (2004). Loss of locus coeruleus neurons and reduced startle in parkin null mice.
  18. (2008). Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.
  19. (2009). Loss of pink1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. The Journal of biological chemistry.
  20. (2007). Loss-offunction of human PINK1 results in mitochondrial pathology and can be rescued by parkin.
  21. (2006). Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.
  22. (2007). Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.
  23. (2005). Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.
  24. (2007). Mitochondrial regulation of neuronal plasticity.
  25. (2008). Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation. Neurochem Res.
  26. (2008). Parkin is recruited selectively to impaired mitochondria and promotes their autophagy.
  27. (2008). Parkin mitochondria in the autophagosome.
  28. (2008). Parkinson patient fibroblasts show increased alpha-synuclein expression. Experimental neurology 212:
  29. (2001). Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families.
  30. (2008). PINK1 controls mitochondrial localization of Parkin through direct phosphorylation.
  31. (2008). PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons.
  32. (2007). PINK1 protects against oxidative stress by phosphoylating mitochondrial chaperone TRAP1. PLoS
  33. (2008). Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery.
  34. (2009). PINK1-associated Parkinson’s disease is caused by neuronal vulnerability to calcium-induced cell death.
  35. (2006). Piracetam improves mitochondrial dysfunction following oxidative stress.
  36. (2006). Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology.
  37. (2005). Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice.
  38. (1979). Stabilization of mitochondrial functions with digitonin.
  39. (1998). Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector.
  40. (2006). Targetdependent specification of the neurotransmitter phenotype: cholinergic differentiation of sympathetic neurons is mediated in vivo by gp 130 signaling.
  41. (2008). The kinase domain of mitochondrial PINK1 faces the cytoplasm.
  42. (2007). The mitochondrial protease HtrA2 is regulated by Parkinson’s disease-associated kinase PINK1.
  43. (2005). The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells.
  44. (2008). The Parkinson’s disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila.
  45. (2008). The PINK1/Parkin pathway regulates mitochondrial morphology.
  46. (1993). The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.
  47. (2003). Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.